Moderna appoints Michael McDonnell to board; shares retreat from 52-week high
Seeking Alpha ·
Moderna ( MRNA ) announced the appointment of Michael McDonnell to its Board of Directors, effective July 8, 2026. He will also join the board's audit committee . McDonnell brings more than three decades of financial leadership experience across life sciences and technology
DYAX Investor Sentiment
Bullish (Long) 45% · Bearish (Short) 55%
448 participants
Related News
- GoPro secures $20M financing from founder and CEO Nicholas Woodman
- White House weighing contenders for FDA's top job
- Multistate lawsuit in Paramount/Warner Bros. deal expected next week - CTFN
- Dow Jones Futures: Oil Spikes On Iran News, But Nvidia, Valero, Dell Rise; SpaceX Hits New Low
- Why SpaceX’s Multi-Billion Dollar Debt Sale Is Already Losing Money for Investors
- SEC won't object to UBS crisis resolution plan